The University of Hawaii Cancer Center (UHCC) is lead by an outstanding group of collaborative and highly interactive senior leaders, each of whom is dedicated to promoting the UHCC mission of discovering, developing and delivering new ways to improve the care of cancer patients in both Hawaii and the world. The Senior Leadership Team is comprised of the Cancer Center Director (Michele Carbone, MD, PhD), the Deputy Director (Marcus Tius, PhD), the Associate Director for Basic Science and Translational Research (David Ward, PhD), the Associate Director for Clinical Sciences and Translational Research (Brian Issell, MD), the Associate Director for Cancer Control and Population Sciences (Herbert Yu, MD, PhD) and the Interim Associate Director for Administration (Shreya Kanodia, PhD). Collectively, these leaders oversee all the Center's activities in basic science, translational research, prevention and control, epidemiology, clinical research and patient treatment, and the shared resources that support the research enterprise. The Senior Leadership Team is convinced that the recent formation of the Hawaii Cancer Consortium will markedly enhance UHCC's ability to conduct translational research, further expanding collaborative interactions between members of Cancer Center programs and clinicians/scientist from the Consortium Partners. Biweekly meetings between the four Associate Directors (Ward, Issell, Yu and Kanodia) take place to ensure forward momentum is maintained. The senior leadership meets at least weekly, either in senior leadership meetings or in executive committee meetings, to discuss issues that include strategic planning, program membership, new recruitment, space allocation, budgetary expenditures, community and media relationships as well as philanthropic and fundraising activities. Individual senior leaders also participate on recruitment search committees, faculty promotion committees. Shared Resource Oversight Committees, faculty mentoring activities and community outreach and education programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA071789-13
Application #
8369405
Study Section
Subcommittee G - Education (NCI)
Project Start
2012-07-01
Project End
2017-06-30
Budget Start
2012-09-21
Budget End
2013-08-31
Support Year
13
Fiscal Year
2012
Total Cost
$165,987
Indirect Cost
$44,562
Name
University of Hawaii
Department
Type
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Huang, Brian Z; Le Marchand, Loic; Haiman, Christopher A et al. (2018) Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study. Int J Cancer 142:2019-2027
Jenkins, Mark A; Win, Aung Ko; Templeton, Allyson S et al. (2018) Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol 47:387-388i
Naderi, Ali (2018) SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies. Mol Oncol 12:724-755
Franke, Adrian A; Li, Xingnan; Menden, Ariane et al. (2018) Oxytocin analysis from human serum, urine, and saliva by orbitrap liquid chromatography-mass spectrometry. Drug Test Anal :
Fanidi, Anouar; Muller, David C; Yuan, Jian-Min et al. (2018) Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). J Natl Cancer Inst 110:
Rohrmann, Sabine; Shvetsov, Yurii B; Morimoto, Yukiko et al. (2018) Self-reported dietary flavonoid intake and serum markers of inflammation: the multiethnic cohort. Cancer Causes Control 29:601-607
Faouzi, Malika; Neupane, Ram P; Yang, Jian et al. (2018) Areca nut extracts mobilize calcium and release pro-inflammatory cytokines from various immune cells. Sci Rep 8:1075
Nishioka, Scott T; Sato, Miles M; Wong, Linda L et al. (2018) Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. Hepatoma Res 4:
Marciel, Michael P; Rose, Aaron H; Martinez, Verena et al. (2018) Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med 7:175-183
Shi, Geng-Xian; Yang, Won Seok; Jin, Ling et al. (2018) RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases. Proc Natl Acad Sci U S A 115:E190-E199

Showing the most recent 10 out of 562 publications